Anti-ar Agent And Radiation Therapy For Androgen Receptor Positive Cancer

Abstract

Provided herein are compositions, systems, kits, and methods for treating cancer in a subject with androgen receptor positive cancer cells by sensitizing such cancer cells with anti-androgen receptor therapy (e.g., Enzalutamide or anti-androgen antibody), and then treating with radiation therapy.


Claims
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Aug 27, 2019
  • Application: Apr 21, 2017
    US US 201715493901 A
  • Priority: Apr 21, 2017
    US US 201715493901 A
  • Priority: Apr 22, 2016
    US US 201662326203 P

Download Citation


Sign in to the Lens

Feedback